BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1593202)

  • 21. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.
    Shiraishi M; Csete M; Yasunaga C; McDiarmid SV; Vannice JL; Busuttil RW; Shaked A
    J Surg Res; 1995 May; 58(5):465-70. PubMed ID: 7745957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term immunosuppression after rat parathyroid allotransplantation.
    Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
    Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental vascularized bone allografting.
    Randolph MA; Yaremchuk MJ; Moore JR; Robinson RA; Weiland AJ
    Microsurgery; 1987; 8(4):210-7. PubMed ID: 3323772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.
    Lanzetta M; Ayrout C; Gal A; Dereli Z; Wright B; Lauer C; Owen ER
    Transplant Proc; 2004 Apr; 36(3):675-9. PubMed ID: 15110628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
    Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of allogeneic vascularized knee transplants.
    Diefenbeck M; Wagner F; Kirschner MH; Nerlich A; Mückley T; Hofmann GO
    Transpl Int; 2007 May; 20(5):410-8. PubMed ID: 17274795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental study on vascularized bone allografts for reconstruction of massive bone defects.
    Shigetomi M; Doi K; Kuwata N; Muramatsu K; Yamamoto H; Kawai S
    Microsurgery; 1994; 15(9):663-70. PubMed ID: 7845198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascularized whole knee joint allografts in rabbits immunosuppressed with cyclosporin A.
    Siliski JM; Simpkin S; Green CJ
    Arch Orthop Trauma Surg (1978); 1984; 103(1):26-35. PubMed ID: 6466061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic vascularized grafting of a human knee joint with postoperative immunosuppression.
    Hofmann GO; Kirschner MH; Wagner FD; Land W; Bühren V
    Arch Orthop Trauma Surg; 1997; 116(3):125-8. PubMed ID: 9061165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An experimental study of the osteogenicity of free periosteal allografts with cyclosporine A administration.
    Hsu M; Umeda H; Nishijima K
    Int J Oral Maxillofac Surg; 1992 Jun; 21(3):178-82. PubMed ID: 1640132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience in allogeneic vascularized bone and joint allografting.
    Hofmann GO; Kirschner MH
    Microsurgery; 2000; 20(8):375-83. PubMed ID: 11150987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental studies on vascularized allogeneic joint grafts].
    Sakuma T
    Nihon Seikeigeka Gakkai Zasshi; 1989 Aug; 63(8):842-51. PubMed ID: 2809363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A vascularized elbow allotransplantation model in the rat.
    Tang J; Zhu H; Luo X; Li Q; Levin LS; Tintle SM
    J Shoulder Elbow Surg; 2015 May; 24(5):779-86. PubMed ID: 25799921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-phase bone imaging and SPECT in the follow up of patients with allogenic vascularized knee joint transplants.
    Manthey N; Kirschner MH; Nerlich A; Hofmann GO; Tatsch K; Hahn K
    Nuklearmedizin; 2001 Dec; 40(6):187-92. PubMed ID: 11797506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints--first clinical experiences.
    Hofmann GO; Kirschner MH; Wagner FD; Brauns L; Gonschorek O; Bühren V
    Transplant Proc; 1998 Sep; 30(6):2754-61. PubMed ID: 9745561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.